Sinco Pharmaceuticals Holdings Ltd. held its Annual General Meeting on 15 May 2025. During the meeting, several proposals were put forward and approved. These included the adoption of the audited consolidated financial statements for the year ended 31 December 2024, the re-election of directors, the re-appointment of the auditor and authorization of the board to fix its remuneration, and the granting of a general mandate to the directors to issue and repurchase shares. All proposals received the necessary approval from shareholders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinco Pharmaceuticals Holdings Ltd. published the original content used to generate this news brief on May 15, 2025, and is solely responsible for the information contained therein.